Its first foray into the myopia-control space, Rodenstock has launched the MyCon lens, designed to correct myopia and ensure sharp vision while controlling axial elongation in children aged 6-14 years.
According to Rodenstock, the MyCon lens ensures sharp central vision by leaving the central zone undisturbed, with the myopia-controlling zones placed on the sides of the lens, diffusing the light so it strikes the periphery in front of the retina. The design was built on principles examined in an independent clinical study led by Professor Elena Tarutta, head of the Helmholtz Research Institute of Eye Diseases, Moscow, demonstrating they are effective in reducing myopia progression by up to 40% and axial length growth by 35%. Examining Caucasian children aged 7-14 years over a five-year period, the study showed the effect was still present after 4-5 years of spectacle wear*.
Compared to other myopia controlling lenses in the market, Rodenstock said MyCon is thinner and lighter and thus more comfortable to wear. Made from shatterproof plastic, it is available in indexes 1.5, 1.6, 1.67, and 1.74.
*The study, ‘Long-term results of perifocal defocus spectacle lens correction in children with progressive myopia’, was published by Vestnik Oftalmologii.
